Cargando…
Alpha-enolase (ENO1), identified as an antigen to monoclonal antibody 12C7, promotes the self-renewal and malignant phenotype of lung cancer stem cells by AMPK/mTOR pathway
BACKGROUND: Tumor-associated antigens (TAAs) can be targeted in cancer therapy. We previously identified a monoclonal antibody (mAb) 12C7, which presented anti-tumor activity in lung cancer stem cells (LCSCs). Here, we aimed to identify the target antigen for 12C7 and confirm its role in LCSCs. METH...
Autores principales: | Shu, Xiong, Cao, Kai-Yue, Liu, Hui-Qi, Yu, Long, Sun, Li-Xin, Yang, Zhi-Hua, Wu, Cheng-Ai, Ran, Yu-Liang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7881626/ https://www.ncbi.nlm.nih.gov/pubmed/33579362 http://dx.doi.org/10.1186/s13287-021-02160-9 |
Ejemplares similares
-
Hypermethylation of the enolase gene (ENO2) in autism
por: Wang, Yu, et al.
Publicado: (2014) -
Alpha-ketoglutarate extends Drosophila lifespan by inhibiting mTOR and activating AMPK
por: Su, Yuan, et al.
Publicado: (2019) -
Alpha-Enolase (ENO1) Correlates with Invasiveness of Cutaneous Melanoma—An In Vitro and a Clinical Study
por: Hippner, Miriam, et al.
Publicado: (2022) -
Arsenic, cadmium and neuron specific enolase (ENO2, γ-enolase) expression in breast cancer
por: Soh, Maureen A, et al.
Publicado: (2011) -
Alpha-enolase regulates the malignant phenotype of pulmonary artery smooth muscle cells via the AMPK-Akt pathway
por: Dai, Jingbo, et al.
Publicado: (2018)